SynCardia Plans U.S. Equivalency Trial Of Portable Total Artificial Heart
This article was originally published in The Gray Sheet
Executive Summary
SynCardia's CardioWest Total Artificial Heart could be used in up to 500 U.S. cardiac transplant candidates annually, according to the firm